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Summary
Background: Point prevalence studies are useful in revealing the prevalence of hospital-acquired
infections (HAIs) and community-acquired infections (CAIs). Such information allows prioritiza-
tion of infection control resources and aids in overall hospital expenditure cut-backs.
Methods: A one-day point prevalence survey was conducted on May 19, 2003 at the King Fahad
National Guard Hospital in Riyadh. Since the survey included HAIs and CAIs all patients were
included. Data were collected on the underlying diagnosis, infection if present and whether it was
hospital-acquired or community-acquired. We identified the presence of a line-associated blood
stream infection (BSI), ventilator-associated pneumonia (VAP), catheter-associated urinary tract
infection (UTI) or a surgical site infection (SSI) based on the United States National Nosocomial
Infection Surveillance (NNIS) definitions.
Results: Five hundred and sixty-two inpatients were included in the survey. There were 38
patients with 45 (8.0%) HAIs and 76 (13.5%) patients with a CAI. Of the HAIs, 31.1% had a line-
related BSI, while 28.9% and 24.4% had a VAP and catheter-related UTI, respectively. Most of the
HAIs took place in the intensive care units (ICU) (21 (46.7%)), followed by the medical and surgical
wards with six (13.3%) cases in each ward. For all HAIs there was a 12.7-fold increased risk with a
hospital stay exceeding eight days (OR: 12.7, CI 3.2—50.6). Most of the 76 CAIs were admitted to
the medical ward with community-acquired pneumonia (34.9%) as the most common diagnosis.
Among the 89 pathogens isolated, Pseudomonas aeruginosa was the most common (21.3%)
followed by Enterococcus spp (16.9%).* Corresponding author. Tel.: +966 01 2520088x3718; fax: +966 01 2520437.
E-mail address: memish@ngha.med.sa (Z.A. Memish).
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Point prevalence infection rates 327Conclusions: The overall rate of HAIs in our hospital was 8%, with significant risk factors including
a hospital stay exceeding eight days. A device-related infection was more likely in a patient with a
venous or bladder catheter in place for more than eight days, or a patient mechanically ventilated
for more than eight days. Catheter-related UTIs were identified as an important source of
infection, requiring ongoing surveillance.
# 2006 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights
reserved.Introduction
Hospital-acquired infections (HAIs) are a significant clinical
and economical burden worldwide.1,2 An estimated 5—10% of
all hospitalizations are complicated by a nosocomial infec-
tion with an estimated cost of $4.5—5.7 billion per year in the
USA alone.3—6 More recently, HAIs have been shown to be a
significant economical burden in developing countries2,7,8
including those of the Middle East. In 1970, Kuwait estimated
that 5.1% of all hospitalizations developed an HAI with a daily
cost of up to $267 000.9
The Gulf Co-operation Council (GCC) states health min-
isters mandated the development of infection control
programs in all its states in 1980. The Kingdom initiated
its infection control program in 15 Ministry of Health (MOH)
hospitals, and by 1987 infection control programs were
extended to all MOH hospitals. Subsequently, infection
control programs were developed in other governmental
hospital sectors including the military, university and private
hospitals. The first Saudi MOH infection control manual was
developed in 1984 with one of its main objectives being to
monitor wards and clinics for infections and to implement
other infection control standards. An infection control pro-
gram was established with the opening of the King Fahad
National Guard Hospital, Riyadh in 1983. As part of its man-
date and ongoing activities it hosts biannual national/inter-
national conferences to address major infection control issues
on travel medicine, bio-terrorism, prevention and manage-
ment of nosocomial infections and training courses in infec-
tion control and hospital epidemiology for medical and non-
medical professionals kingdomwide.10,11
As the primary aim, a one-day point prevalence survey was
conducted to identify the extent of HAIs and the most likely
risk factors leading to such infections in our facility. A second
aim was to identify the prevalence of inpatients with com-
munity-acquired infections (CAIs) and the diseases necessi-
tating their admissions. Since our surveillance program and
activities are targeted by focusing on patients in specific risk
groups,12—15 this undertaking served as an adjunct to provide
us with information on the infection status of our patients at
a single point in time.
Methods
A one-day point prevalence survey was conducted at the
King Fahad National Guard Hospital, King Abdulaziz Medical
City, a 700-bed tertiary care center in Riyadh, Saudi Arabia
on May 19, 2003. All hospital wards were included in the
point prevalence survey. Affiliated to the infection control
department are four infection control practitioners (ICPs),
three infectious disease specialists and four public health
nurses.Experienced and certified ICPs and the infectious disease
specialists developed the questionnaire form. Infection con-
trol practitioners were responsible for data collection and
the training and supervision of additional staff that assisted
in data collection. This included three public health nurses
who are part of the Infection Control Department and two
members from the Quality Management Department.
A main focus was HAIs involving line-related blood stream
infections (BSIs), ventilator-associated pneumonias (VAPs),
surgical site infections (SSIs), and catheter-related urinary
tract infections (UTIs), and to separate these from CAIs. An
infectionwas determined to be anHAI or a CAI based onUnited
States National Nosocomial Infection Surveillance (NNIS)16
definitions and was listed on each data collection sheet.
The forms were reviewed and discussed with all the members
participating in the data collection to emphasize the impor-
tance of data completeness. Standard information was col-
lected on all patients in all wards. Each data collection sheet
was composed of four sections. Section 1 detailed patient
demographics and date of admission; section 2 the presence of
a peripheral intravenous line or central line and any related
infection, an endotracheal tube and any related infection, a
foley catheter and any related infection, and a surgical site
infection; section 3 detailed the presence of an HAI and the
type of infection or a CAI and the type of infection; and section
4 detailed the results of pertinent microbiological samples
tested, the pathogen isolated and the antibiotic sensitivity
patterns. All microbiological samples that were taken in rela-
tion to the infection accounting for either an HAI or a CAI were
reviewedandassessedonfinal reporting fromthemicrobiology
laboratory. The infectious diseases/hospital epidemiologist
reviewed all 569 completed forms for further analysis.
Statistical methodology
All questionnaires on the point prevalence survey were
checked and edited to ensure consistency of information.
Statistical analysis was carried out using statistical software
SAS version 8.2. Univariate and multivariate analyses of
association of HAIs with all the risk factors were performed
using the classical approach for analysis of the 2  k con-
tingency tables and then repeated using logistic regression.
Maximum likelihood estimates of odds ratio (OR) together
with 95% confidence intervals (CIs) and the result of like-
lihood ratio tests for significance were computed with a p
value of <0.05 used for statistical significance.
Results
General patient characteristics
On the day of the survey the hospital had an occupancy rate
of 80% and a total of 562 patients were included in the study;
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Figure 1 Distribution of HAIs and CAIs according to ward
specialty — May 19, 2003.
Table 1 Demographic data
All infections Non-infected Total
HAI CAI
No. (%) No. % No. % No. %
Sex
Male 31a 68.9 44 57.9 229 51.1 304 53.4
Female 14 31.1 32 42.1 219 48.9 265 46.6
Total 45 100.0 76 100.0 448 100.0 569b 100.0
Age group
<1 Year 8 17.8 6 7.9 47 10.5 61 10.8
1—9 3 6.7 11 14.5 54 12.1 68 12.0
10—19 4 8.9 5 6.6 24 5.4 33 5.8
20—29 9 20.0 5 6.6 71 15.8 84 14.8
30—39 4 8.9 3 3.9 65 14.5 72 12.7
40—49 3 6.7 13 17.1 32 7.1 47 8.3
50+ 14 31.1 33 43.4 155 34.6 202 35.6
Total 45 100.0 76 100.0 448 100.0 569b 100.0
Table shows data relating to episodes of infection. One patient from each age group (except the age group 20—29) had two infections each. In
the age group 50+ two patients had a double infection.
a Seven male patients had two infections each (seven patients counted twice, 24 male patients had 31 infections).
b 562 patients had a total of 569 infections (448 patients non-infected, 114 patients infected).there were 297 males and 265 females. The average age was
36.8 years among themales while the females had an average
age of 36.2 years.
Of the 562 patients surveyed 114 [38 HAI patients + 76 CAI
patients] had an infectious process (Table 1). Seven patients
had two infections leading to a total of 121 [45 HAIs + 76 CAIs]
infections. All of the seven patients who had two infections
were male and all were HAIs.
Hospital-acquired infections
The prevalence for HAIs was 8%. Themajority of patients with
an HAI were above the age of 50 (31.1%), followed by the age
group 20—29 (20%) (Table 1). Among the pediatric group aged
0—19 years, more children under the age of one year (n = 7,
58.3%) had an infection compared to those above 50 years in
the adult age group 20 years and above (n = 12, 46.2%)
(statistics not detailed in Table 1).
The most common HAI was line-related BSIs (n = 14,
31.1%), followed by VAPs (n = 13, 28.9%) and catheter related
UTIs (n = 11, 24.4%). Among the HAIs, 21 (46.7%) occured in
the ICUs, while in each of the medical and surgical wards, six
(13.3%) HAIs occured (Table 2, Figure 1). The majority of HAIs
in the ICU were VAPs (47.6%), followed by line-related BSIs
and catheter-related UTIs (19%) each.
There was no increased risk of developing an HAI when
comparing males and females or among the different age
groups. However, the risk of developing an HAI was 9.1 times
higher among patients who were admitted to the ICU in
comparison to those admitted to non-ICU wards (Table 3).
The likelihood of developing an HAI was 16.4 times higher for
those with a hospital stay exceeding eight days, and the
likelihood of developing a catheter-related UTI was 10 times
higher in patients catheterized for more than eight days
( p < 0.005). The risk of developing a line-related BSI or a
VAP was much higher in those who had a line or wereventilated for more than eight days ( p < 0.005) (Table 3).
On the surgical wards, six HAIs were documented, none were
surgical site infections (SSIs) and the only wound infection
documented was a bed sore (Table 2).
Community-acquired infections
The prevalence of patients admitted with a CAI in the survey
was 13.5%. The majority of patients admitted to the hospital
with a CAI were above 50 years of age, followed by the age
group 40—49. At the time of the survey none of the patients
admitted with a CAI developed an HAI (Table 1). The most
common admission diagnosis was community-acquired pneu-
monia, accounting for 30.3% of all CAIs. This was followed by
UTIs not related to the presence of a catheter, and BSIs not
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Table 2 Distribution of HAIs and CAIs among different hospital wards
Type of infection Wards
Intensive care
units a
Medical wards Surgical wards Gynecology
wards
Pediatric
wards
Rehabilitation
and long-term
Others Total
No. % No. % No. % No. % No. % No. % No. % No. %
Hospital-acquired infections
BSI 4 19.0 0 0.0 1 16.7 1 100 2 100.0 3 75.0 3 60.0 14 31.1
VAP 10 47.6 0 0.0 3 50.0 0 0.0 0 0.0 0 0.0 0 0.0 13 28.9
UTI 4 19.0 3 50.0 1 16.7 0 0.0 0 0.0 1 25.0 2 40.0 11 24.4
Pneumonia 1 4.8 1 16.7 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 2 4.4
Wound infection 2b 9.5 0 0.0 1b 16.7 0 0.0 0 0.0 0 0.0 0 0.0 3 6.7
Others 0 0.0 2 33.3 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 2 4.4
Total 21 100 6 100 6 100 1 100 2 100 4 100 5 100 45 100
Community-acquired infection
BSI 2 50.0 6 14.0 0 0.0 0 0.0 4 26.7 0 0.0 0 0.0 12 15.8
VAP 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 2 40.0 0 0.0 2 2.6
UTI 1 25.0 10 23.3 0 0.0 0 0.0 2 13.3 0 0.0 2 66.7 15 19.7
Pneumonia 1 25.0 15 34.9 0 0.0 0 0.0 6 40.0 1 20.0 0 0.0 23 30.3
Others 0 0.0 12 27.9 6 100 0 0.0 3 20.0 2 40.0 1 33.3 24 31.6
Total 4 100 43 100 6 100 0 0 15 100 5 100 3 100 76 100
BSI: bloodstream infection; VAP: ventilator-associated pneumonia; UTI: urinary tract infection.
a ICUs include: adult and pediatric cardiac and burn ICUs, PICU and NICU.
b No surgical site infection.
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Table 3 Prevalence of HAIs according to patient characteristics (including risk factors) and specialties
HAIs Non-infecteda Prevalence of HAIs (%) Odds ratio p valueb (95% CI)
Sex
Male 31 229 10.5 1 p = 0.02
Female 14 219 5.3 0.47 (0.24—0.90)
Age group
<1 8 47 13.3 1 p = 0.38
1—49 23 246 7.7 0.55 (0.23—1.3)
50 14 155 7.0 0.53 (0.21—1.34)
Specialties
Medicine 6 98 4.1 1 p < 0.0001
Surgery 6 63 8.1 1.56 (0.48—5.0)
Obstetrics-gynecology 1 20 4.8 0.82 (0.09—7.2)
Pediatrics 2 55 2.8 0.59 (0.12—3.04)
Intensive care 21 45 31.3 7.6 (2.9—20.2)
Rehabilitation and long-term 4 68 5.5 0.96 (0.22—4.04)
Others 5 99 5.0 0.84 (0.21—3.25)
Length of hospital stay
<8 days 3 251 1.0 1 p < 0.0001
8—13 days 9 46 14.8 16.4 (4.3—62.8) p < 0.0001
>13 days 33 149 16.8 18.5 (5.6—61.5) p < 0.0001
Patients with a urinary catheter and UTI
<8 days 1 251 0.3 1 p = 0.00
8—13 days 2 46 3.3 10.9 (0.97—122.8) 0.053
>13 days 8 149 4.1 13.5 (1.67—108.8) 0.015
Patients with an ETT/ventilated and VAP
<8 days 2 251 0.7 1 p = 0.00
8—13 days 4 46 6.6 10.9 (1.9—61.3) 0.007
>13 days 7 149 3.6 5.9 (1.2—28.7) 0.028
Patients with a PIV/CVL and a blood stream infectionc
<8 days 0.5 251.5 0.2 1 p < 0.0001
8—13 days 2.5 46.5 4.1 27.0 (1.3—572.4) 0.034
>13 days 12.5 149.5 6.3 42.0 (2.5—715.5) 0.0097
UTI: urinary tract infection; ETT: endotracheal tube; VAP: ventilator-associated pneumonia; PIV: peripheral intravenous line; CVL: central
venous line.
a Excluding CAIs.
b p < 0.05 is significant.
c 0.5 added to each cell due to zero value in one cell, to determine p value and 95% confidence interval.related to the presence of a line, 19.7% and 15.8%, respec-
tively (Table 2). Most of the CAIs were on the medical wards
(n = 43, 56.6%), followed by the pediatric wards (n = 15,
19.7%) (Table 2).
Microbiology data
All 121 episodes of infections had at least one clinical sample
sent formicrobiological testing as deemed appropriate by the
managing team. A pathogen was isolated from 89 samples of
89 episodes of infection with no duplicates included. The
most frequently isolated pathogens in descending order
were, Pseudomonas aeruginosa (21.3%), Enterococcus spp
(16.9%), Klebsiella spp (10.1%), Staphylococcus spp, includ-
ing methicillin-sensitive Staphylococcus aureus (MSSA) and
methicillin-resistant Staphylococcus aureus (MRSA) (13.5%)
(Table 4).Discussion
Point prevalence survey studies are conducted over one day
and the results are expected to differ in the same hospital
depending mainly on the time of year, patient volume and
service load. For example, our survey was conducted in the
middle of May, when the city of Riyadh is just exiting the
winter season and many admissions are related to lower
respiratory tract infections secondary to viral pathogens,
such as respiratory syncytial virus (RSV) and influenza. This
would explain our higher numbers of community-acquired
respiratory infections compared to HAIs, a ratio of 1.7:1.
In a similar point prevalence survey conducted by Azzam
and Dramaix in Lebanon, the HAI prevalence rate was 6.8%,
slightly lower than our rate of 8%.17 However, similar to our
results, the ICUs had the highest rates of HAIs, 18.4%, fol-
lowed by the medical wards, 5.8%. These results concur with
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Table 4 Distribution of 89 pathogens from the point prevalence survey — May 19, 2003
Pathogen isolated Positive cultures
HAIs CAIs p Value Total
No. (%) No. (%) No. (%)
Gram-negative pathogens
Pseudomonas aeruginosa 12 63.2 7 36.8 0.16 19 21.3
Klebsiella spp 8 88.9 1 11.1 0.42 9 10.1
Pseudomonas spp 6 85.7 1 14.3 0.39 7 7.9
Enterobacter spp 2 33.3 4 66.7 0.20 6 6.7
Haemophilus spp 3 75.0 1 25.0 0.29 4 4.5
Other Gram-negative bacilli 1 16.7 5 83.3 0.37 6 6.7
Gram-positive pathogens
MSSA 6 85.7 1 14.3 0.39 7 7.9
MRSA 4 80.0 1 20.0 0.29 5 5.6
Streptococcus pneumoniae 0 0.0 2 100.0 0.50 2 2.2
Other Streptococcus spp 2 100.0 0 0.0 0.50 2 2.2
CoNS a 3 42.9 4 57.1 0.09 7 7.9
Enterococcus spp 11 73.3 4 26.7 0.28 15 16.9
Total 58 64.8 31 35.2 0.2 89 100.0
MSSA: methicillin-susceptible Staphylococcus aureus; MRSA: methicillin-resistant Staphylococcus aureus.
a Coagulase negative staphylococcus.many other studies from the developed countries, where the
majority of HAIs occur in the ICUs.16,18,19 This is to be
expected since ICU patients are more likely to be critically
ill and to endure multiple invasive procedures and indwelling
lines. In a prospective survey conducted over a six-month
period from a tertiary care hospital in Abu Dhabi, three areas
were included, the ICU, male orthopedic ward and general
surgery ward, and the prevalence of HAIs was highest among
the ICU patients, 29.1%, followed by patients of the male
orthopedic ward and general surgery ward, 6.5% and 5.7%,
respectively.20
The most common HAI in our survey was line-related BSIs.
This was in contrast to the results of Azzam and Dramaix17
and El-Hagrassy,20 where VAPs were the most common among
the HAIs, while a report from Abha, Saudi Arabia, documen-
ted UTIs as the most common HAI.21 The differences could be
related to several factors, most importantly the definition
used for HAIs, which may vary among the different studies,
and the variation among patient populations. In our study,
VAPs ranked second among the ICU HAIs. Our department has,
for many years, been making major efforts to reduce the
magnitude of VAPs in our ICUs. A prospective surveillance
system has been in place since its implementation in 1996.
Memish et al. reported a high VAP prevalence rate among the
adult ICU patients between 1996 and 1997, 16.8/1000 venti-
lator days.22 A second prospective study conducted over a
two-year period among pediatric ICU (PICU) patients
revealed a lower VAP rate of 8.87/1000 ventilator days23,
but almost double the NNIS PICU VAP rate of 4.9/1000
ventilator days.16 Since then our hospital has implemented
some preventative measures to reduce the VAP rates among
our ICU patients. Heat and moisture exchanges were intro-
duced on a trial basis, then became a standard of care in all
ventilated patients with no contraindication.24
The design of our study, unfortunately, did not outline the
different risk factors leading to HAIs such as co-morbidityfactors and previous hospitalizations and surgical proce-
dures. We were, however, able to show a possible association
between a prolonged hospital stay and the occurrence of an
HAI. Similarly, a significant increase in hospital-acquired BSIs,
VAPs and UTIs with prolonged instrumentation is suggested by
the data. This has clearly been proven by many other stu-
dies.25—27 For line-related BSIs the Centers for Disease Con-
trol (CDC) has published guidelines to assist ICU patient
caregivers in reducing the rates of line-related infections.13
Similarly, guidelines for improving the standard of care given
to patients who are ventilated or have a bladder catheter, in
order to reduce the rates of VAPs and UTIs are available.28,29
The CDC has clearly recommended the presence of an author-
itative and leading infection control department whose
members would assist in implementing and monitoring these
guidelines.3,30,31
As with other reports, Gram-negative pathogens were
responsible for most HAIs. Our samples, though, were too
small to detect a statistical significance between pathogens
causing HAIs and CAIs. From the 89 isolates, 12 were Sta-
phylococcus aureus, five of which were MRSA. Of the latter,
four were HAIs and one was a CAI indicating that 40% of HAIs
secondary to S. aureuswere MRSA infections. This was similar
to a study published from Jeddah in 2001 where the pre-
valence of MRSA in two tertiary care hospitals was 33%.32
Most of these isolates were from the ICU followed by the
general medical wards. The emergence of MRSA as a major
nosocomial pathogen has been recognized worldwide, and in
major cities in the USA, MRSA in hospitals has risen from less
than 3% to over 30% within the past three decades.33,34 More
alarming though, is the documented rise in the number of
CAIs with MRSA and the major economic impact it has on the
medical care system. Bukharie et al., from the Eastern
province of Saudi Arabia, have shown a 15-fold increase in
the number of MRSA-related CAIs over a three-year period.35
In our institution there is an ongoing prospective survey to
332 H.H. Balkhy et al.monitor MRSA infections and to ensure compliance with
infection control practices of standard precautions and con-
tact isolation when indicated, to limit the spread of such
infections among patients. Our MRSA rate has remained
between 10 and 15% over the last five years.36
Several points may be concluded from our study. A crude
baseline HAI rate has been established. Our high rate of line-
related BSIs mandate further investigation andmore detailed
surveys to outline the risk factors and possible methods of
reducing their occurrence. Secondly, continuous surveillance
on VAP should take place. Initiating a survey to monitor the
occurrences of catheter-related UTIs would be critical to
establish rates and plan interventional strategies. Finally, a
more comprehensive survey to look into the magnitude of the
misuse of antimicrobials in our institution should take place
since we are keen on reducing the emergence of resistant
pathogens, a problem that seems to be a major cause for
concern in developing countries where considerable misuse
of antibiotics is prevalent.
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